XLY Stock UPDATES Consumer Discret Select Sector SPDR (XLY) 68.77

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Consumer Discret Select Sector SPDR (XLY) 68.77 $XLY

Consumer Spending Drives Stock Market to Record Highs
at The Street - Thu Aug 28, 9:58AM CDT
Improved consumer spending has underlined the stock market's rally, signaling more gains ahead

Which Sectors Are You Betting On? - Real Time Insight
Todd Bunton - ZACKS - Wed Aug 13, 3:35PM CDT
Which sectors do you think will outperform or underperform throughout the rest of 2014?

Uptick in Consumer Spending Could Mean a Second-Half Market Rally
at The Street - Mon Aug 11, 10:47AM CDT
The consumer discretionary sector has outperformed consumer staples companies over the past few months.

Sideways Stocks = Sideways Consumers? - Real Time Insight
John Blank - Zacks Investment Research - Fri Aug 08, 7:46AM CDT
Are Range-Bound Stock Markets Slowing Consumer Growth?

Disney Posts Solid Earnings: 3 ETFs to Watch - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Aug 07, 5:00AM CDT
After Disney's earnings, these Consumer Discretionary ETFs will be in focus in the coming days.

How Many More 100-Point-Swing Days on the DJIA Can You Take?
at The Street - Mon Jul 28, 4:43PM CDT
The stock indexes fluctuated wildly on Monday as the hedge funds trading the S&P between the daily trading range.

China Food Safety and Poor Earnings Put These Consumer ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 24, 11:00AM CDT
Thanks to more issues for Yum and McDonalds in China, these consumer ETFs could face some rocky trading ahead.

'Fast Money' Recap: Confusion in the Market
at The Street - Fri Jul 11, 4:00AM CDT
The trading panel discussed whether investors are too complacent and whether it's a good idea to buy Microsoft again.

Could Earnings Prove Consumer Goods Pessimists Wrong?
Joseph Hogue, The Motley Fool - Motley Fool - Thu Jul 10, 6:00PM CDT
The consumer discretionary group is the only sector that posted a loss for the first half of the year, as it trailed the S&P 500 by more than 6%. Poor consumer spending in the first quarter drove earnings expectations lower and analysts largely...

Utilities, Energy, Health Care Are the ETFs to Beat This Year
at The Street - Thu Jul 03, 10:10AM CDT
I track 11 exchange-traded funds, and the best year-to-date performer is utilities, while health care set an all-time high on Wednesday.

'Fast Money' Recap: Let Your Winning Trades Keep Running
at The Street - Wed Jul 02, 4:00AM CDT
The trading panel discussed yet another closing high for the S&P 500 and DJIA plus what they are buying and selling.

This U.S. Stock Market Is Not Dealing in Reality as It Moves Higher
at The Street - Mon Jun 30, 4:32PM CDT
The stock market on Monday closed out the second quarter in mixed fashion. The DJIA is oversold while the Nasdaq is overbought.

A Stock Market Selloff With Some Volume and Power Behind It
at The Street - Tue Jun 24, 4:20PM CDT
The stock indexes closed down on Tuesday after an intraday turn from the upside. The downside volume was big in comparison to the upside volume for the past month.

The Zacks Analyst Blog Highlights owerShares Dynamic Building & Construction, Consumer Discretionary Select Sector SPDR Fund, Industrials/Producer Durables AlphaDEX Fund and SPDR S&P 500 ETF
PR Newswire - Tue Jun 24, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the PowerShares Dynamic Building & Construction (AMEX KB-Free Report), Consumer Discretionary Select Sector SPDR Fund (AMEX:XLY-Free Report), Industrials/Producer Durables AlphaDEX Fund (AMEX:FXR-Free Report) and SPDR S&P 500 ETF (AMEX:SPY-Free Report).

3 Cyclical ETFs to Buy in a Rebounding U.S. Economy - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Jun 23, 11:00AM CDT
These sector ETFs could benefit from a rebounding American economy.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 319

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 283

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 462

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 81

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 246

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading

Top 5 Most Recently Viewed Articles

New Partnership Expands Eco-Friendly Solutions in the South

Updated Category News Views 234

Expanding Environmental Solutions in the Southern States Easy Environmental Solutions Inc., formerly known as Digital Utilities Ventures, is excited to announce a significant partnership with Organic Living Soil, LLC. As the exclusive dealer for Easy Environmental Solutions in Louisiana and Mississippi, Organic Living Soil aims to revolutionize the way eco-friendly...

Continue Reading
Michael Young Enhances Ty J. Young Wealth Management Team

Updated Category News Views 244

Michael Young Joins Ty J. Young Wealth Management Ty J. Young Wealth Management, a prominent name in financial services, proudly announces the appointment of Michael Young as Vice President of Business Development. With a wealth of experience from his previous role as a sales executive in a Fortune 500 company, Young is set to take the lead in expanding the firm's...

Continue Reading
Johnson & Johnson Advances Myeloma Treatment with FDA Application

Updated Category News Views 289

Johnson & Johnson took a big swing back in 2024 when they submitted a supplemental Biologics License Application (sBLA) for their myeloma treatment, DARZALEX FASPRO®. This move aimed at getting the green light from the FDA for use among newly diagnosed multiple myeloma patients who couldn't go through autologous stem cell transplants. Desks buzzed with chatter on how...

Continue Reading
What Investors Should Anticipate in ScanSource's Earnings Report

Updated Category News Views 121

ScanSource's Earnings Report: Expectations and Insights ScanSource (NASDAQ:SCSC) is gearing up to release its quarterly earnings report soon. Investors are particularly interested in the results that are expected to be announced shortly. With the anticipation building, understanding what to look for is essential. Predicted Earnings Results Industry experts have estimated...

Continue Reading
Revealing the Truth: IRS Data Access by Immigration Authorities

Updated Category News Views 127

IRS Data Accessed by Immigration Authorities: An Overview Federal immigration officials gained access to taxpayer information from the IRS during the previous administration's deportation efforts, though they claim this data was not used to identify individuals for removal. This raises serious questions surrounding privacy and immigration enforcement. Cross-Referencing...

Continue Reading